Skip to main content
. 2021 Jun 21;49(3):258–266. doi: 10.1080/12298093.2021.1926122

Table 2.

Oligonucleotides used in this study.

Name Sequence (5′→3′)a Purpose
OHS0089 GCTGAAGTCATGATACAGGCCAAA 5′ AfupyrG marker_F
OHS0090 ATCGTCGGGAGGTATTGTCGTCAC 3′ AfupyrG marker_R
OHS0281 ATCAGACTCAGAGTGCCGTCC 5′ vidD DF
OHS0282 GCCGAAGGAGGGGTAATCAAT 3′ vidD DR
OHS0283 GGCTTTGGCCTGTATCATGACTTCA TATCGCAAGAGCATGAATATCG 3′ vidD with AfupyrG tail
OHS0284 TTTGGTGACGACAATACCTCCCGAC GCACAACCAGACAGTACCTTGG 5′ vidD with AfupyrG tail
OHS0285 ACACATCTTCGTGCCCACCT 5′ vidD NF
OHS0286 GCGCTATTTCTGGCATAGGCG 3′ vidD NR
OHS0914 aatt GCGGCCGC CTCTTCGCACACCGAGG 5′ vidD with promoter_NotI
OHS0460 aatt GCGGCCGC GGCAGTTCGCTTTCGCAG 3′ vidD with NotI
OHS0449 CCACCGAAGAGGATGCCATA 5′ vidD RT_F
OHS0450 AGATCCACTTGCCGAGAGAG 3′ vidD RT_R
OHS0576 GGTTGAAGTCGTCGGTTGAG 5′ tpsA RT_F
OHS0577 TGGAAACCGATGAGGTCACA 3′ tpsA RT_R
OHS0616 CTCCTACTCGCGTCACTTCT 5′ orlA RT_F
OHS0617 AGGAAAGACATCCACAGCCA 3′ orlA RT_R

aTail sequences are shown in italics. Restriction enzyme sites are in bold.